<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
<channel>
<title>Merit Medical Systems Inc — News on 6ix</title>
<link>https://6ix.com/company/merit-medical-systems-inc</link>
<description>Latest news and press releases for Merit Medical Systems Inc on 6ix.</description>
<language>en-us</language>
<lastBuildDate>Thu, 30 Apr 2026 20:05:00 GMT</lastBuildDate>
<generator>6ix RSS</generator>
<atom:link href="https://6ix.com/rss/company/merit-medical-systems-inc" rel="self" type="application/rss+xml" />
<image>
<url>https://6ix-events-pro.s3.amazonaws.com/6ixvideo/logos/org-logo68359b4e78dffbe2df106ab7.webp</url>
<title>Merit Medical Systems Inc</title>
<link>https://6ix.com/company/merit-medical-systems-inc</link>
</image>
<item>
<title>Merit Medical Reports First Quarter 2026 Results and Updates Full-Year Guidance</title>
<link>https://6ix.com/company/merit-medical-systems-inc/news/merit-medical-reports-first-quarter-2026-results-and-updates-full-year-guidance</link>
<guid isPermaLink="true">https://6ix.com/company/merit-medical-systems-inc/news/merit-medical-reports-first-quarter-2026-results-and-updates-full-year-guidance</guid>
<pubDate>Thu, 30 Apr 2026 20:05:00 GMT</pubDate>
<description>Financial Highlights† Reported revenue of $381.9 million, up 7%Constant currency revenue* and constant currency revenue, organic* up 5% and up 3%, respectively Constant currency revenue, organic* increased 4%, excluding revenue from divested product line GAAP operating margin of 11.6%, compared to 11.5% in prior year periodNon-GAAP operating margin* of 19.7%, compared to 19.3% in prior year periodGAAP EPS $0.68, up 39%Non-GAAP EPS* $0.94, up 9%Free cash flow* generation of $24.7 million, up 26%</description>
</item>
<item>
<title>Merit Medical Systems to Announce First Quarter 2026 Results on April 30, 2026</title>
<link>https://6ix.com/company/merit-medical-systems-inc/news/merit-medical-systems-to-announce-first-quarter-2026-results-on-april-30-2026</link>
<guid isPermaLink="true">https://6ix.com/company/merit-medical-systems-inc/news/merit-medical-systems-to-announce-first-quarter-2026-results-on-april-30-2026</guid>
<pubDate>Thu, 02 Apr 2026 04:00:00 GMT</pubDate>
<description>SOUTH JORDAN, Utah, April 02, 2026 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a global leader of healthcare technology, announced today</description>
</item>
<item>
<title>Merit Medical Acquires View Point Medical, Inc., expanding the Merit Therapeutic Oncology Portfolio</title>
<link>https://6ix.com/company/merit-medical-systems-inc/news/merit-medical-acquires-view-point-medical-inc-expanding-the-merit-therapeutic-oncology-portfolio</link>
<guid isPermaLink="true">https://6ix.com/company/merit-medical-systems-inc/news/merit-medical-acquires-view-point-medical-inc-expanding-the-merit-therapeutic-oncology-portfolio</guid>
<pubDate>Wed, 01 Apr 2026 04:00:00 GMT</pubDate>
<description>SOUTH JORDAN, Utah, April 01, 2026 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a global leader of healthcare technology, today announced</description>
</item>
<item>
<title>Medtronic and Merit Medical Systems enter into agreement to offer new, FDA-cleared ViaVerte™ system, a basivertebral nerve ablation treatment for chronic vertebrogenic lower-back pain</title>
<link>https://6ix.com/company/merit-medical-systems-inc/news/medtronic-and-merit-medical-systems-enter-into-agreement-to-offer-new-fda-cleared-viavertetm-system-a-basivertebral-nerve-ablation-treatment-for-chronic-vertebrogenic-lower-back-pain</link>
<guid isPermaLink="true">https://6ix.com/company/merit-medical-systems-inc/news/medtronic-and-merit-medical-systems-enter-into-agreement-to-offer-new-fda-cleared-viavertetm-system-a-basivertebral-nerve-ablation-treatment-for-chronic-vertebrogenic-lower-back-pain</guid>
<pubDate>Tue, 24 Mar 2026 04:00:00 GMT</pubDate>
<description>Exclusive agreement expands Medtronic's comprehensive pain interventions portfolio, increases treatment options for patients living with chronic pain GALWAY,</description>
</item>
<item>
<title>Merit Medical Launches the Resilience Through-the-Scope Esophageal Stent</title>
<link>https://6ix.com/company/merit-medical-systems-inc/news/merit-medical-launches-the-resilience-through-the-scope-esophageal-stent</link>
<guid isPermaLink="true">https://6ix.com/company/merit-medical-systems-inc/news/merit-medical-launches-the-resilience-through-the-scope-esophageal-stent</guid>
<pubDate>Mon, 16 Mar 2026 04:00:00 GMT</pubDate>
<description>New Resilience™ deployment system, anti-migration stent design, and unique stent sizes offer physicians control while enhancing treatment for patients with</description>
</item>
<item>
<title>Merit Medical Reports Fourth Quarter and Full Year 2025 Results and Issues Fiscal Year 2026 Guidance</title>
<link>https://6ix.com/company/merit-medical-systems-inc/news/merit-medical-reports-fourth-quarter-and-full-year-2025-results-and-issues-fiscal-year-2026-guidance</link>
<guid isPermaLink="true">https://6ix.com/company/merit-medical-systems-inc/news/merit-medical-reports-fourth-quarter-and-full-year-2025-results-and-issues-fiscal-year-2026-guidance</guid>
<pubDate>Tue, 24 Feb 2026 21:05:00 GMT</pubDate>
<description>Fourth Quarter Highlights† Reported revenue of $393.9 million, up 11%Constant currency revenue* and constant currency revenue, organic* up 10% and up 7%, respectivelyGAAP operating margin of 13.8%, compared to 10.3% in prior year periodNon-GAAP operating margin* of 21.0%, compared to 19.6% in prior year periodGAAP EPS $0.63, up 37%Non-GAAP EPS* $1.04, up 12%Free cash flow* generation of $74.0 million, up 13% Fiscal Year 2025 Highlights† Reported revenue of $1.516 billion, up 12%Constant currency</description>
</item>
<item>
<title>Merit Medical Appoints F. Ann Millner as Chair of the Board and Announces Projected Preliminary Unaudited Revenue Results for the Fourth Quarter of 2025</title>
<link>https://6ix.com/company/merit-medical-systems-inc/news/merit-medical-appoints-f-ann-millner-chair-board-and-announces-projected-preliminary</link>
<guid isPermaLink="true">https://6ix.com/company/merit-medical-systems-inc/news/merit-medical-appoints-f-ann-millner-chair-board-and-announces-projected-preliminary</guid>
<pubDate>Thu, 08 Jan 2026 05:00:00 GMT</pubDate>
<description>SOUTH JORDAN, Utah, Jan. 08, 2026 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a global leader in healthcare technology, today announced</description>
</item>
<item>
<title>Merit Medical to Participate at the J.P. Morgan Healthcare Conference</title>
<link>https://6ix.com/company/merit-medical-systems-inc/news/merit-medical-participate-jp-morgan-healthcare-conference-2025-12-23</link>
<guid isPermaLink="true">https://6ix.com/company/merit-medical-systems-inc/news/merit-medical-participate-jp-morgan-healthcare-conference-2025-12-23</guid>
<pubDate>Tue, 23 Dec 2025 05:00:00 GMT</pubDate>
<description>SOUTH JORDAN, Utah, Dec. 23, 2025 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a global leader in healthcare technology, today announced</description>
</item>
<item>
<title>Merit Medical Provides Update on U.S. Reimbursement and Commercial Strategies for WRAPSODY® Cell-Impermeable Endoprosthesis</title>
<link>https://6ix.com/company/merit-medical-systems-inc/news/merit-medical-provides-update-us-reimbursement-and-commercial-strategies-wrapsodyr</link>
<guid isPermaLink="true">https://6ix.com/company/merit-medical-systems-inc/news/merit-medical-provides-update-us-reimbursement-and-commercial-strategies-wrapsodyr</guid>
<pubDate>Thu, 13 Nov 2025 05:00:00 GMT</pubDate>
<description>SOUTH JORDAN, Utah, Nov. 13, 2025 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a global leader of healthcare technology, announced today</description>
</item>
<item>
<title>Merit Medical Releases 24-Month Efficacy Results from the Randomized Arteriovenous Fistula (AVF) Arm of the WRAPSODY Arteriovenous Access Efficacy (WAVE) Trial</title>
<link>https://6ix.com/company/merit-medical-systems-inc/news/merit-medical-releases-24-month-efficacy-results-randomized-arteriovenous-fistula-avf</link>
<guid isPermaLink="true">https://6ix.com/company/merit-medical-systems-inc/news/merit-medical-releases-24-month-efficacy-results-randomized-arteriovenous-fistula-avf</guid>
<pubDate>Wed, 05 Nov 2025 05:00:00 GMT</pubDate>
<description>The target lesion primary patency (TLPP)1 and access circuit primary patency (ACPP)2 of the WRAPSODY® Cell-Impermeable Endoprosthesis (CIE) remain superior to</description>
</item>
<item>
<title>Merit Medical Releases 24-Month Efficacy Results from the Single-Arm Arteriovenous Graft (AVG) Cohort of the WRAPSODY Arteriovenous Access Efficacy (WAVE) Trial</title>
<link>https://6ix.com/company/merit-medical-systems-inc/news/merit-medical-releases-24-month-efficacy-results-single-arm-arteriovenous-graft-avg</link>
<guid isPermaLink="true">https://6ix.com/company/merit-medical-systems-inc/news/merit-medical-releases-24-month-efficacy-results-single-arm-arteriovenous-graft-avg</guid>
<pubDate>Mon, 03 Nov 2025 05:00:00 GMT</pubDate>
<description>At 24 months, the target lesion primary patency (TLPP)1 was 41.7%At 24 months, the access circuit primary patency (ACPP)2 was 25.7% SOUTH JORDAN, Utah, Nov.</description>
</item>
<item>
<title>Merit Medical Reports Third Quarter 2025 Results and Updates Full-Year Guidance</title>
<link>https://6ix.com/company/merit-medical-systems-inc/news/merit-medical-reports-third-quarter-2025-results-and-updates-full-year-guidance-2025</link>
<guid isPermaLink="true">https://6ix.com/company/merit-medical-systems-inc/news/merit-medical-reports-third-quarter-2025-results-and-updates-full-year-guidance-2025</guid>
<pubDate>Thu, 30 Oct 2025 04:00:00 GMT</pubDate>
<description>Highlights† Reported revenue of $384.2 million, up 13.0%Constant currency revenue* and constant currency revenue, organic* up 12.5% and up 7.8%,</description>
</item>
<item>
<title>Merit Medical Signs Asset Purchase Agreement with PENTAX Medical to Acquire C2 CryoBalloon Technology</title>
<link>https://6ix.com/company/merit-medical-systems-inc/news/merit-medical-signs-asset-purchase-agreement-pentax-medical-acquire-c2-cryoballoon</link>
<guid isPermaLink="true">https://6ix.com/company/merit-medical-systems-inc/news/merit-medical-signs-asset-purchase-agreement-pentax-medical-acquire-c2-cryoballoon</guid>
<pubDate>Wed, 15 Oct 2025 04:00:00 GMT</pubDate>
<description>Asset acquisition would expand Merit’s Endoscopy portfolio with an innovative device to treat patients suffering from Barretts esophagus and other</description>
</item>
<item>
<title>Merit Medical Systems to Announce Third Quarter 2025 Results on October 30, 2025</title>
<link>https://6ix.com/company/merit-medical-systems-inc/news/merit-medical-systems-announce-third-quarter-2025-results-october-30-2025-2025-10-03</link>
<guid isPermaLink="true">https://6ix.com/company/merit-medical-systems-inc/news/merit-medical-systems-announce-third-quarter-2025-results-october-30-2025-2025-10-03</guid>
<pubDate>Fri, 03 Oct 2025 04:00:00 GMT</pubDate>
<description>SOUTH JORDAN, Utah, Oct. 03, 2025 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading global manufacturer and marketer of healthcare</description>
</item>
<item>
<title>Merit Medical Announces SCOUT Milestone: 750,000 Patients Treated with Wire-Free Technology</title>
<link>https://6ix.com/company/merit-medical-systems-inc/news/merit-medical-announces-scout-milestone-750000-patients-treated-wire-free-technology</link>
<guid isPermaLink="true">https://6ix.com/company/merit-medical-systems-inc/news/merit-medical-announces-scout-milestone-750000-patients-treated-wire-free-technology</guid>
<pubDate>Wed, 01 Oct 2025 04:00:00 GMT</pubDate>
<description>SCOUT Radar Localization use grows, supporting more successful surgeries and improved patient care SOUTH JORDAN, Utah, Oct. 01, 2025 (GLOBE NEWSWIRE) -- Merit</description>
</item>
<item>
<title>Merit Medical Embosphere Microspheres Achieve CE Mark for Genicular Artery Embolisation to Treat Knee Osteoarthritis</title>
<link>https://6ix.com/company/merit-medical-systems-inc/news/merit-medical-embosphere-microspheres-achieve-ce-mark-genicular-artery-embolisation</link>
<guid isPermaLink="true">https://6ix.com/company/merit-medical-systems-inc/news/merit-medical-embosphere-microspheres-achieve-ce-mark-genicular-artery-embolisation</guid>
<pubDate>Fri, 12 Sep 2025 04:00:00 GMT</pubDate>
<description>Expanded indication provides patients with knee osteoarthritis the benefits of Embosphere’s consistent, predictable, and effective clinical results. SOUTH</description>
</item>
<item>
<title>First Patient Enrolled in Merit Medical’s WRAPSODY (WRAP) North America Registry</title>
<link>https://6ix.com/company/merit-medical-systems-inc/news/first-patient-enrolled-merit-medicals-wrapsody-wrap-north-america-registry-2025-08-18</link>
<guid isPermaLink="true">https://6ix.com/company/merit-medical-systems-inc/news/first-patient-enrolled-merit-medicals-wrapsody-wrap-north-america-registry-2025-08-18</guid>
<pubDate>Mon, 18 Aug 2025 04:00:00 GMT</pubDate>
<description>The WRAP North America registry is a prospective, multicenter study designed to collect real-world safety and effectiveness data on the WRAPSODY®</description>
</item>
<item>
<title>Merit Medical Launches the Prelude Wave Hydrophilic Sheath Introducer with SnapFix Technology</title>
<link>https://6ix.com/company/merit-medical-systems-inc/news/merit-medical-launches-prelude-wave-hydrophilic-sheath-introducer-snapfix-technology</link>
<guid isPermaLink="true">https://6ix.com/company/merit-medical-systems-inc/news/merit-medical-launches-prelude-wave-hydrophilic-sheath-introducer-snapfix-technology</guid>
<pubDate>Thu, 07 Aug 2025 04:00:00 GMT</pubDate>
<description>Thin-wall design with superior insertion and unique sheath-securement solution to support successful radial access procedures and may aid in reducing arterial</description>
</item>
<item>
<title>Merit Medical Reports Second Quarter 2025 Results and Updates Full-Year Guidance</title>
<link>https://6ix.com/company/merit-medical-systems-inc/news/merit-medical-reports-second-quarter-2025-results-and-updates-full-year-guidance-2025</link>
<guid isPermaLink="true">https://6ix.com/company/merit-medical-systems-inc/news/merit-medical-reports-second-quarter-2025-results-and-updates-full-year-guidance-2025</guid>
<pubDate>Wed, 30 Jul 2025 04:00:00 GMT</pubDate>
<description>Highlights† Reported revenue of $382.5 million, up 13.2%Constant currency revenue* and constant currency revenue, organic* up 12.5% and up 6.7%,</description>
</item>
<item>
<title>Martha Aronson to Step Down from CONMED Board of Directors Following Appointment as President and Chief Executive Officer of Merit Medical Systems, Inc.</title>
<link>https://6ix.com/company/merit-medical-systems-inc/news/martha-aronson-to-step-down-from-conmed-board-of-directors-following-appointment-as-president-and-chief-executive-officer-of-merit-medical-systems-inc</link>
<guid isPermaLink="true">https://6ix.com/company/merit-medical-systems-inc/news/martha-aronson-to-step-down-from-conmed-board-of-directors-following-appointment-as-president-and-chief-executive-officer-of-merit-medical-systems-inc</guid>
<pubDate>Mon, 07 Jul 2025 21:00:00 GMT</pubDate>
<description>LARGO, Fla., July 07, 2025--CONMED Corporation (NYSE: CNMD) today announced that Martha Aronson will be stepping down from the company’s Board of Directors to assume the role of President and Chief Executive Officer at Merit Medical, a global leader in the development, manufacture and distribution of proprietary medical devices. Mrs. Aronson’s resignation from the Board will be effective July 7, 2025, as she transitions to her new leadership responsibilities.</description>
</item>
</channel>
</rss>